Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of membrane maker Polypore International
So what: Baird analyst Richard Eastman upgraded the company to outperform and raised his price target to $43. Investors jumped on the news, pushing the stock up to $41.25 and leaving very little upside if Eastman's price target is right.
Now what: Polypore has done a nice job swinging back to a profit, but it still sits at a 26 forward price-to-earnings ratio, making shares pretty expensive. Plus, I can't help but think this analyst is a little late to the party since shares have more than tripled over the past year. I look at today's move with a skeptical eye, and I'd like to see fundamentals move the stock instead of an analyst who is jumping aboard a hot stock.
Interested in more info on Polypore? Add it to your watchlist.
Fool contributor Travis Hoium does not have a position in any company mentioned. You can follow Travis on Twitter at @FlushDrawFool, check out his personal stock holdings or follow his CAPS picks at TMFFlushDraw.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.